Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial Medical Device Investing
Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets Life Science Investing
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems Pharmaceutical Investing
US FDA Approves Intramuscular Administration for Merck's MMRV Family of Vaccines: M-M-RII , VARIVAX , and ProQuad Life Science Investing
Late-Breaking Data from Landmark COAPT Trial Show Long-Term Benefits of Abbott's MitraClip Device Pharmaceutical Investing
New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval of Reblozyl® for Anemia in Adult Patients with Non-Transfusion-Dependent Beta Thalassemia Pharmaceutical Investing
COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care Conference, Oppenheimer 33rd Annual Healthcare Conference, and Loop Capital Investor Conference Psychedelics Investing
